Growing community of inventors

Lalor, Australia

Donia Moujalled

Average Co-Inventor Count = 5.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Donia MoujalledOlivier Geneste (1 patent)Donia MoujalledEnsar Halilovic (1 patent)Donia MoujalledAna Leticia Maragno (1 patent)Donia MoujalledYouzhen Wang (1 patent)Donia MoujalledAndrew Wei (1 patent)Donia MoujalledGiovanna Pomilio (1 patent)Donia MoujalledAna-Leticia Maragno (1 patent)Donia MoujalledSneha Sanghavi (1 patent)Donia MoujalledPrakash Mistry (1 patent)Donia MoujalledHeiko Maacke (1 patent)Donia MoujalledAna-Leticia Maragno (0 patent)Donia MoujalledDale Porter (1 patent)Donia MoujalledErick Morris (1 patent)Donia MoujalledAudrey Claperon (1 patent)Donia MoujalledDonia Moujalled (1 patent)Olivier GenesteOlivier Geneste (34 patents)Ensar HalilovicEnsar Halilovic (5 patents)Ana Leticia MaragnoAna Leticia Maragno (3 patents)Youzhen WangYouzhen Wang (2 patents)Andrew WeiAndrew Wei (1 patent)Giovanna PomilioGiovanna Pomilio (1 patent)Ana-Leticia MaragnoAna-Leticia Maragno (1 patent)Sneha SanghaviSneha Sanghavi (3 patents)Prakash MistryPrakash Mistry (3 patents)Heiko MaackeHeiko Maacke (3 patents)Ana-Leticia MaragnoAna-Leticia Maragno (0 patent)Dale PorterDale Porter (3 patents)Erick MorrisErick Morris (2 patents)Audrey ClaperonAudrey Claperon (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (1 from 3,923 patents)

2. Les Laboratoires Servier (1 from 290 patents)


1 patent:

1. 11466023 - Combination of a Mcl-1 inhibitor and a standard of care treatment for hematologic cancers, uses and pharmaceutical compositions thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…